Multi-gene panel testing has recently emerged as a safe and effective way to identify genetic mutations known to increase risk for breast cancer. Compared with earlier genetic tests, which required initial testing for BRCA1 and BRCA2 followed by subsequent testing for other cancer-related genes, multi-gene panel testing can evaluate up to 43 genes. At Breastlink, we recently conducted a study to see how multi-gene panel testing affected treatment and screening decisions in cancer survivors who had previously tested negative for BRCA1/2.
The Impact of Multi-Gene Panel Testing for Cancer Survivors16 Jan 2016 in
Trends in Ductal Carcinoma In Situ Survival Rates21 Dec 2015 in
The long-term survival rate for women diagnosed with ductal carcinoma in situ (DCIS) or non-invasive breast cancer is excellent, according to a new study released in August. The study, “Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ” revealed that this held true regardless of the type of treatment.
Chemotherapy Side Effects in Breast Cancer Patients09 Nov 2015 in
Medical advancements allow us to treat breast cancer more effectively than ever before. However, side effects can occur as a result of treatment. Many breast cancer patients receive some combination of surgery, radiation therapy and chemotherapy. Chemotherapy side effects can range from being a temporary nuisance to having a sustained negative impact on quality of life. As oncologists, it is our job to help patients avoid, lessen or completely eliminate such side effects.
What are Some of the Common Side Effects of Chemotherapy?
Chemotherapy for Breast Cancer26 Oct 2015 in
Chemotherapy is one of the most common treatment methods for fighting breast cancer. Typically used in combination with surgery, chemotherapy helps to kill breast cancer cells whether they reside within the breast or have managed to escape throughout the body.